This evidence indicates that vasoactive neuropeptide dysregulation constitutes a primary mechanism underlying microvascular dysfunction and subsequent cognitive decline in vascular cognitive impairment, providing potential targets for therapeutic intervention. This evidence concerns the gene NPS and Mental deterioration.